Valuation : PolyPid Ltd.

Market Cap 10Cr 8.91Cr 8.36Cr 7.64Cr 14Cr 989.96Cr 14Cr 99Cr 38Cr 499.43Cr 39Cr 38Cr 1.65TCr P/E 2026 *
-5.74x
P/E 2027 * -4.16x
Enterprise Value 10Cr 8.91Cr 8.36Cr 7.64Cr 14Cr 989.96Cr 14Cr 99Cr 38Cr 499.43Cr 39Cr 38Cr 1.65TCr EV / Sales 2026 *
6.92x
EV / Sales 2027 * 12x
Free-Float
79.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.20%
1 week+2.00%
Current month+19.11%
1 month+31.03%
3 months+5.58%
6 months+21.09%
Current year+17.74%
1 week 4.96
Extreme 4.96
5.23
1 month 3.71
Extreme 3.713898
5.23
Current year 3.65
Extreme 3.65
5.73
1 year 3.06
Extreme 3.06
5.73
3 years 2.3
Extreme 2.3
9.75
5 years 2.3
Extreme 2.3
289.2
10 years 2.3
Extreme 2.3
583.5
Manager TitleAgeSince
Chief Executive Officer 52 01/07/2022
Director of Finance/CFO 39 -
Chief Tech/Sci/R&D Officer 61 18/08/2025
Director TitleAgeSince
Director/Board Member 84 01/04/2008
Director/Board Member 52 08/08/2022
Director/Board Member 74 01/12/2018
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Free

Director

9,132 0.0896%
15/07/26 Free

Director

9,132 0.0896%
15/07/26 Free

Chairman

9,132 0.0896%
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%+2.00%+49.42%-46.79% 10Cr
-3.59%-7.10%+61.60%+114.83% 1,06000Cr
-1.15%-1.25%+52.98%+62.41% 65TCr
-1.09%-1.15%+26.18%+79.22% 46TCr
-0.96%-1.96%+38.80%+40.65% 37TCr
-1.07%-0.44%+23.34%+39.04% 30TCr
-0.47%+1.03%+2.55%+12.69% 26TCr
-0.43%-0.46%+52.06%+71.75% 24TCr
-1.70%+0.98%-16.16%-53.74% 21TCr
-0.46%+0.33%+29.05%+92.67% 18TCr
Average -1.07%-0.40%+31.98%+41.27% 37.31TCr
Weighted average by Cap. -1.71%-2.16%+39.70%+67.49%

Financials

2026 *2027 *
Net sales 1.5Cr 1.29Cr 1.21Cr 1.1Cr 2.08Cr 143.07Cr 2.09Cr 14Cr 5.54Cr 72Cr 5.63Cr 5.51Cr 239.06Cr 86.75L 74.46L 69.89L 63.83L 1.2Cr 83Cr 1.21Cr 8.27Cr 3.21Cr 42Cr 3.26Cr 3.19Cr 138.25Cr
Net income -2Cr -1.72Cr -1.61Cr -1.47Cr -2.78Cr -191Cr -2.79Cr -19Cr -7.4Cr -96Cr -7.52Cr -7.36Cr -319.16Cr -3.15Cr -2.71Cr -2.54Cr -2.32Cr -4.38Cr -300.92Cr -4.4Cr -30Cr -12Cr -151.81Cr -12Cr -12Cr -502.81Cr
Net Debt - -
Logo PolyPid Ltd.
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Employees
72
Date Price Change Volume
26/26/26 $5.110 +0.20% 1,49,344
25/26/25 $5.100 +2.31% 1,39,606
24/26/24 $4.985 -2.25% 1,24,422
21/26/21 $5.100 +0.39% 1,69,113
20/26/20 $5.080 +1.40% 1,29,450
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.110USD
Average target price
11.75USD
Spread / Average Target
+129.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PYPD Stock